Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
Frontiers Editorial Office
Frontiers in Oncology · 2021
doi:10.3389/fonc.2021.694036 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
“Following publication, concerns were raised regarding manipulation in figures 5 and 7. An investigation was conducted in accordance with Frontiers’ guidelines and the authors failed to provide a satisfactory explanation.This retraction was approved by the Chief Editors of Frontiers in Oncology and the Editor-in-Chief of Frontiers. The authors agree to this retraction.”
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.